HEADER VIRAL PROTEIN/RNA 14-DEC-20 7L1F TITLE SARS-COV-2 RDRP IN COMPLEX WITH 4 REMDESIVIR MONOPHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: POL, RDRP, NON-STRUCTURAL PROTEIN 12, NSP12; COMPND 5 EC: 2.7.7.48; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NON-STRUCTURAL PROTEIN 8; COMPND 9 CHAIN: C; COMPND 10 SYNONYM: NSP8; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: NON-STRUCTURAL PROTEIN 7; COMPND 14 CHAIN: D; COMPND 15 SYNONYM: NSP7; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 4; COMPND 18 MOLECULE: RNA (5'-R(P*CP*UP*AP*AP*GP*AP*AP*GP*CP*UP*AP*UP*U*(F86) COMPND 19 *(F86)*(F86)*(F86))-3'); COMPND 20 CHAIN: P; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 5; COMPND 23 MOLECULE: RNA (5'- COMPND 24 R(P*AP*UP*UP*UP*UP*AP*AP*UP*AP*GP*CP*UP*UP*CP*UP*UP*AP*G)-3'); COMPND 25 CHAIN: T; COMPND 26 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: REP, 1A-1B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 11 2; SOURCE 12 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 13 ORGANISM_TAXID: 2697049; SOURCE 14 GENE: REP, 1A-1B; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 19 2; SOURCE 20 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 21 ORGANISM_TAXID: 2697049; SOURCE 22 GENE: REP, 1A-1B; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 25 MOL_ID: 4; SOURCE 26 SYNTHETIC: YES; SOURCE 27 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 28 2; SOURCE 29 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 30 ORGANISM_TAXID: 2697049; SOURCE 31 MOL_ID: 5; SOURCE 32 SYNTHETIC: YES; SOURCE 33 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 34 2; SOURCE 35 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 36 ORGANISM_TAXID: 2697049 KEYWDS VIRAL PROTEIN, VIRAL PROTEIN-RNA COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR J.P.K.BRAVO,D.W.TAYLOR REVDAT 3 06-MAR-24 7L1F 1 LINK REVDAT 2 26-MAY-21 7L1F 1 JRNL REVDAT 1 10-FEB-21 7L1F 0 JRNL AUTH J.P.K.BRAVO,T.L.DANGERFIELD,D.W.TAYLOR,K.A.JOHNSON JRNL TITL REMDESIVIR IS A DELAYED TRANSLOCATION INHIBITOR OF JRNL TITL 2 SARS-COV-2 REPLICATION. JRNL REF MOL.CELL V. 81 1548 2021 JRNL REFN ISSN 1097-2765 JRNL PMID 33631104 JRNL DOI 10.1016/J.MOLCEL.2021.01.035 REMARK 2 REMARK 2 RESOLUTION. 3.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : FOURIER SPACE REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.890 REMARK 3 NUMBER OF PARTICLES : 116748 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7L1F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000253533. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 RDRP COMPLEX WITH REMARK 245 TEMPLATE:PRIMER AND FOUR RMP; REMARK 245 RNA-DIRECTED RNA POLYMERASE, REMARK 245 NON-STRUCTURAL PROTEIN 8, NON- REMARK 245 STRUCTURAL PROTEIN 7; RNA REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 8000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, P, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 51 REMARK 465 ASN A 52 REMARK 465 CYS A 53 REMARK 465 CYS A 54 REMARK 465 ARG A 55 REMARK 465 PHE A 56 REMARK 465 GLN A 57 REMARK 465 GLU A 58 REMARK 465 LYS A 59 REMARK 465 ASP A 60 REMARK 465 GLU A 61 REMARK 465 ASP A 62 REMARK 465 ASP A 63 REMARK 465 ASN A 64 REMARK 465 LEU A 65 REMARK 465 ILE A 66 REMARK 465 ASP A 67 REMARK 465 SER A 68 REMARK 465 TYR A 69 REMARK 465 PHE A 70 REMARK 465 VAL A 71 REMARK 465 VAL A 72 REMARK 465 LYS A 73 REMARK 465 ARG A 74 REMARK 465 HIS A 75 REMARK 465 THR A 76 REMARK 465 PHE A 77 REMARK 465 SER A 78 REMARK 465 ASN A 79 REMARK 465 TYR A 80 REMARK 465 GLN A 81 REMARK 465 HIS A 82 REMARK 465 GLU A 83 REMARK 465 PHE A 101 REMARK 465 PHE A 102 REMARK 465 LYS A 103 REMARK 465 PHE A 104 REMARK 465 ARG A 105 REMARK 465 ILE A 106 REMARK 465 ASP A 107 REMARK 465 GLY A 108 REMARK 465 ASP A 109 REMARK 465 MET A 110 REMARK 465 VAL A 111 REMARK 465 PRO A 112 REMARK 465 HIS A 113 REMARK 465 ILE A 114 REMARK 465 SER A 115 REMARK 465 ARG A 116 REMARK 465 GLN A 117 REMARK 465 ARG A 118 REMARK 465 THR A 896 REMARK 465 GLY A 897 REMARK 465 HIS A 898 REMARK 465 MET A 899 REMARK 465 LEU A 900 REMARK 465 ASP A 901 REMARK 465 MET A 902 REMARK 465 TYR A 903 REMARK 465 SER A 904 REMARK 465 VAL A 905 REMARK 465 MET A 906 REMARK 465 LEU A 907 REMARK 465 THR A 908 REMARK 465 ASN A 909 REMARK 465 ASP A 910 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 207 CA - CB - CG ANGL. DEV. = 14.4 DEGREES REMARK 500 ASP A 304 CB - CG - OD1 ANGL. DEV. = 11.9 DEGREES REMARK 500 ASP A 304 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 LYS A 411 CB - CG - CD ANGL. DEV. = 15.8 DEGREES REMARK 500 ASP A 454 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 VAL A 557 C - N - CA ANGL. DEV. = 15.8 DEGREES REMARK 500 PRO C 183 C - N - CD ANGL. DEV. = -15.6 DEGREES REMARK 500 A T 0 C2 - N3 - C4 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 33 -169.14 -124.44 REMARK 500 THR A 85 56.88 -96.98 REMARK 500 CYS A 139 35.15 -98.81 REMARK 500 ASP A 161 69.20 62.38 REMARK 500 ASP A 221 20.70 -140.58 REMARK 500 SER A 384 35.36 -98.39 REMARK 500 LYS A 426 30.27 -98.61 REMARK 500 THR A 556 -81.80 -96.34 REMARK 500 TYR A 606 39.10 -94.30 REMARK 500 THR A 686 38.27 -99.52 REMARK 500 SER A 709 31.08 -95.73 REMARK 500 ARG A 733 -2.43 -142.39 REMARK 500 SER A 759 -18.67 68.64 REMARK 500 ASP A 760 -26.76 -145.12 REMARK 500 ARG D 21 65.20 60.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR A 556 VAL A 557 148.03 REMARK 500 LEU C 98 ASP C 99 -149.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-23109 RELATED DB: EMDB REMARK 900 SARS-COV-2 RDRP IN COMPLEX WITH 4 REMDESIVIR MONOPHOSPHATE DBREF 7L1F A 32 929 UNP P0DTD1 R1AB_SARS2 4424 5321 DBREF 7L1F C 78 191 UNP P0DTD1 R1AB_SARS2 4020 4133 DBREF 7L1F D 2 64 UNP P0DTD1 R1AB_SARS2 3861 3923 DBREF 7L1F P 1 17 PDB 7L1F 7L1F 1 17 DBREF 7L1F T 0 17 PDB 7L1F 7L1F 0 17 SEQRES 1 A 898 TYR ARG ALA PHE ASP ILE TYR ASN ASP LYS VAL ALA GLY SEQRES 2 A 898 PHE ALA LYS PHE LEU LYS THR ASN CYS CYS ARG PHE GLN SEQRES 3 A 898 GLU LYS ASP GLU ASP ASP ASN LEU ILE ASP SER TYR PHE SEQRES 4 A 898 VAL VAL LYS ARG HIS THR PHE SER ASN TYR GLN HIS GLU SEQRES 5 A 898 GLU THR ILE TYR ASN LEU LEU LYS ASP CYS PRO ALA VAL SEQRES 6 A 898 ALA LYS HIS ASP PHE PHE LYS PHE ARG ILE ASP GLY ASP SEQRES 7 A 898 MET VAL PRO HIS ILE SER ARG GLN ARG LEU THR LYS TYR SEQRES 8 A 898 THR MET ALA ASP LEU VAL TYR ALA LEU ARG HIS PHE ASP SEQRES 9 A 898 GLU GLY ASN CYS ASP THR LEU LYS GLU ILE LEU VAL THR SEQRES 10 A 898 TYR ASN CYS CYS ASP ASP ASP TYR PHE ASN LYS LYS ASP SEQRES 11 A 898 TRP TYR ASP PHE VAL GLU ASN PRO ASP ILE LEU ARG VAL SEQRES 12 A 898 TYR ALA ASN LEU GLY GLU ARG VAL ARG GLN ALA LEU LEU SEQRES 13 A 898 LYS THR VAL GLN PHE CYS ASP ALA MET ARG ASN ALA GLY SEQRES 14 A 898 ILE VAL GLY VAL LEU THR LEU ASP ASN GLN ASP LEU ASN SEQRES 15 A 898 GLY ASN TRP TYR ASP PHE GLY ASP PHE ILE GLN THR THR SEQRES 16 A 898 PRO GLY SER GLY VAL PRO VAL VAL ASP SER TYR TYR SER SEQRES 17 A 898 LEU LEU MET PRO ILE LEU THR LEU THR ARG ALA LEU THR SEQRES 18 A 898 ALA GLU SER HIS VAL ASP THR ASP LEU THR LYS PRO TYR SEQRES 19 A 898 ILE LYS TRP ASP LEU LEU LYS TYR ASP PHE THR GLU GLU SEQRES 20 A 898 ARG LEU LYS LEU PHE ASP ARG TYR PHE LYS TYR TRP ASP SEQRES 21 A 898 GLN THR TYR HIS PRO ASN CYS VAL ASN CYS LEU ASP ASP SEQRES 22 A 898 ARG CYS ILE LEU HIS CYS ALA ASN PHE ASN VAL LEU PHE SEQRES 23 A 898 SER THR VAL PHE PRO PRO THR SER PHE GLY PRO LEU VAL SEQRES 24 A 898 ARG LYS ILE PHE VAL ASP GLY VAL PRO PHE VAL VAL SER SEQRES 25 A 898 THR GLY TYR HIS PHE ARG GLU LEU GLY VAL VAL HIS ASN SEQRES 26 A 898 GLN ASP VAL ASN LEU HIS SER SER ARG LEU SER PHE LYS SEQRES 27 A 898 GLU LEU LEU VAL TYR ALA ALA ASP PRO ALA MET HIS ALA SEQRES 28 A 898 ALA SER GLY ASN LEU LEU LEU ASP LYS ARG THR THR CYS SEQRES 29 A 898 PHE SER VAL ALA ALA LEU THR ASN ASN VAL ALA PHE GLN SEQRES 30 A 898 THR VAL LYS PRO GLY ASN PHE ASN LYS ASP PHE TYR ASP SEQRES 31 A 898 PHE ALA VAL SER LYS GLY PHE PHE LYS GLU GLY SER SER SEQRES 32 A 898 VAL GLU LEU LYS HIS PHE PHE PHE ALA GLN ASP GLY ASN SEQRES 33 A 898 ALA ALA ILE SER ASP TYR ASP TYR TYR ARG TYR ASN LEU SEQRES 34 A 898 PRO THR MET CYS ASP ILE ARG GLN LEU LEU PHE VAL VAL SEQRES 35 A 898 GLU VAL VAL ASP LYS TYR PHE ASP CYS TYR ASP GLY GLY SEQRES 36 A 898 CYS ILE ASN ALA ASN GLN VAL ILE VAL ASN ASN LEU ASP SEQRES 37 A 898 LYS SER ALA GLY PHE PRO PHE ASN LYS TRP GLY LYS ALA SEQRES 38 A 898 ARG LEU TYR TYR ASP SER MET SER TYR GLU ASP GLN ASP SEQRES 39 A 898 ALA LEU PHE ALA TYR THR LYS ARG ASN VAL ILE PRO THR SEQRES 40 A 898 ILE THR GLN MET ASN LEU LYS TYR ALA ILE SER ALA LYS SEQRES 41 A 898 ASN ARG ALA ARG THR VAL ALA GLY VAL SER ILE CYS SER SEQRES 42 A 898 THR MET THR ASN ARG GLN PHE HIS GLN LYS LEU LEU LYS SEQRES 43 A 898 SER ILE ALA ALA THR ARG GLY ALA THR VAL VAL ILE GLY SEQRES 44 A 898 THR SER LYS PHE TYR GLY GLY TRP HIS ASN MET LEU LYS SEQRES 45 A 898 THR VAL TYR SER ASP VAL GLU ASN PRO HIS LEU MET GLY SEQRES 46 A 898 TRP ASP TYR PRO LYS CYS ASP ARG ALA MET PRO ASN MET SEQRES 47 A 898 LEU ARG ILE MET ALA SER LEU VAL LEU ALA ARG LYS HIS SEQRES 48 A 898 THR THR CYS CYS SER LEU SER HIS ARG PHE TYR ARG LEU SEQRES 49 A 898 ALA ASN GLU CYS ALA GLN VAL LEU SER GLU MET VAL MET SEQRES 50 A 898 CYS GLY GLY SER LEU TYR VAL LYS PRO GLY GLY THR SER SEQRES 51 A 898 SER GLY ASP ALA THR THR ALA TYR ALA ASN SER VAL PHE SEQRES 52 A 898 ASN ILE CYS GLN ALA VAL THR ALA ASN VAL ASN ALA LEU SEQRES 53 A 898 LEU SER THR ASP GLY ASN LYS ILE ALA ASP LYS TYR VAL SEQRES 54 A 898 ARG ASN LEU GLN HIS ARG LEU TYR GLU CYS LEU TYR ARG SEQRES 55 A 898 ASN ARG ASP VAL ASP THR ASP PHE VAL ASN GLU PHE TYR SEQRES 56 A 898 ALA TYR LEU ARG LYS HIS PHE SER MET MET ILE LEU SER SEQRES 57 A 898 ASP ASP ALA VAL VAL CYS PHE ASN SER THR TYR ALA SER SEQRES 58 A 898 GLN GLY LEU VAL ALA SER ILE LYS ASN PHE LYS SER VAL SEQRES 59 A 898 LEU TYR TYR GLN ASN ASN VAL PHE MET SER GLU ALA LYS SEQRES 60 A 898 CYS TRP THR GLU THR ASP LEU THR LYS GLY PRO HIS GLU SEQRES 61 A 898 PHE CYS SER GLN HIS THR MET LEU VAL LYS GLN GLY ASP SEQRES 62 A 898 ASP TYR VAL TYR LEU PRO TYR PRO ASP PRO SER ARG ILE SEQRES 63 A 898 LEU GLY ALA GLY CYS PHE VAL ASP ASP ILE VAL LYS THR SEQRES 64 A 898 ASP GLY THR LEU MET ILE GLU ARG PHE VAL SER LEU ALA SEQRES 65 A 898 ILE ASP ALA TYR PRO LEU THR LYS HIS PRO ASN GLN GLU SEQRES 66 A 898 TYR ALA ASP VAL PHE HIS LEU TYR LEU GLN TYR ILE ARG SEQRES 67 A 898 LYS LEU HIS ASP GLU LEU THR GLY HIS MET LEU ASP MET SEQRES 68 A 898 TYR SER VAL MET LEU THR ASN ASP ASN THR SER ARG TYR SEQRES 69 A 898 TRP GLU PRO GLU PHE TYR GLU ALA MET TYR THR PRO HIS SEQRES 70 A 898 THR SEQRES 1 C 114 ASP LYS ARG ALA LYS VAL THR SER ALA MET GLN THR MET SEQRES 2 C 114 LEU PHE THR MET LEU ARG LYS LEU ASP ASN ASP ALA LEU SEQRES 3 C 114 ASN ASN ILE ILE ASN ASN ALA ARG ASP GLY CYS VAL PRO SEQRES 4 C 114 LEU ASN ILE ILE PRO LEU THR THR ALA ALA LYS LEU MET SEQRES 5 C 114 VAL VAL ILE PRO ASP TYR ASN THR TYR LYS ASN THR CYS SEQRES 6 C 114 ASP GLY THR THR PHE THR TYR ALA SER ALA LEU TRP GLU SEQRES 7 C 114 ILE GLN GLN VAL VAL ASP ALA ASP SER LYS ILE VAL GLN SEQRES 8 C 114 LEU SER GLU ILE SER MET ASP ASN SER PRO ASN LEU ALA SEQRES 9 C 114 TRP PRO LEU ILE VAL THR ALA LEU ARG ALA SEQRES 1 D 63 LYS MET SER ASP VAL LYS CYS THR SER VAL VAL LEU LEU SEQRES 2 D 63 SER VAL LEU GLN GLN LEU ARG VAL GLU SER SER SER LYS SEQRES 3 D 63 LEU TRP ALA GLN CYS VAL GLN LEU HIS ASN ASP ILE LEU SEQRES 4 D 63 LEU ALA LYS ASP THR THR GLU ALA PHE GLU LYS MET VAL SEQRES 5 D 63 SER LEU LEU SER VAL LEU LEU SER MET GLN GLY SEQRES 1 P 17 C U A A G A A G C U A U U SEQRES 2 P 17 F86 F86 F86 F86 SEQRES 1 T 18 A U U U U A A U A G C U U SEQRES 2 T 18 C U U A G HET F86 P 14 24 HET F86 P 15 24 HET F86 P 16 24 HET F86 P 17 24 HETNAM F86 [(2~{R},3~{S},4~{R},5~{R})-5-(4-AZANYLPYRROLO[2,1-F][1, HETNAM 2 F86 2,4]TRIAZIN-7-YL)-5-CYANO-3,4-BIS(OXIDANYL)OXOLAN-2- HETNAM 3 F86 YL]METHYL DIHYDROGEN PHOSPHATE HETSYN F86 REMDESIVIR, BOUND FORM FORMUL 4 F86 4(C12 H14 N5 O7 P) HELIX 1 AA1 THR A 123 ALA A 130 1 8 HELIX 2 AA2 CYS A 139 TYR A 149 1 11 HELIX 3 AA3 ASP A 170 ALA A 176 1 7 HELIX 4 AA4 LEU A 178 GLY A 200 1 23 HELIX 5 AA5 THR A 206 GLN A 210 5 5 HELIX 6 AA6 VAL A 234 ARG A 249 1 16 HELIX 7 AA7 THR A 276 PHE A 287 1 12 HELIX 8 AA8 ARG A 305 SER A 318 1 14 HELIX 9 AA9 SER A 367 ASP A 377 1 11 HELIX 10 AB1 PRO A 378 ALA A 383 1 6 HELIX 11 AB2 ASN A 416 VAL A 424 1 9 HELIX 12 AB3 ASN A 447 ASP A 454 1 8 HELIX 13 AB4 TYR A 455 ASN A 459 5 5 HELIX 14 AB5 ILE A 466 VAL A 476 1 11 HELIX 15 AB6 ASP A 477 PHE A 480 5 4 HELIX 16 AB7 ASN A 489 VAL A 493 5 5 HELIX 17 AB8 PRO A 505 TRP A 509 5 5 HELIX 18 AB9 ARG A 513 SER A 518 1 6 HELIX 19 AC1 SER A 520 THR A 531 1 12 HELIX 20 AC2 SER A 561 ALA A 580 1 20 HELIX 21 AC3 GLY A 596 TYR A 606 1 11 HELIX 22 AC4 PRO A 627 LEU A 638 1 12 HELIX 23 AC5 SER A 647 LEU A 663 1 17 HELIX 24 AC6 THR A 686 SER A 709 1 24 HELIX 25 AC7 ASP A 717 ARG A 733 1 17 HELIX 26 AC8 ASP A 738 HIS A 752 1 15 HELIX 27 AC9 SER A 778 GLN A 789 1 12 HELIX 28 AD1 ASP A 833 CYS A 842 1 10 HELIX 29 AD2 ILE A 847 THR A 850 5 4 HELIX 30 AD3 ASP A 851 ALA A 866 1 16 HELIX 31 AD4 ASN A 874 LEU A 895 1 22 HELIX 32 AD5 GLU A 917 TYR A 925 1 9 HELIX 33 AD6 LYS C 79 MET C 94 1 16 HELIX 34 AD7 ASN C 100 ASN C 108 1 9 HELIX 35 AD8 PRO C 116 ASN C 118 5 3 HELIX 36 AD9 ILE C 119 ALA C 125 1 7 HELIX 37 AE1 ASP C 134 CYS C 142 1 9 HELIX 38 AE2 SER C 173 SER C 177 5 5 HELIX 39 AE3 MET D 3 GLN D 19 1 17 HELIX 40 AE4 SER D 25 LEU D 40 1 16 HELIX 41 AE5 THR D 45 MET D 62 1 18 SHEET 1 AA1 2 ALA A 34 TYR A 38 0 SHEET 2 AA1 2 ALA A 43 LYS A 47 -1 O GLY A 44 N ILE A 37 SHEET 1 AA2 3 ILE A 223 GLN A 224 0 SHEET 2 AA2 3 ILE A 201 VAL A 204 -1 N VAL A 202 O ILE A 223 SHEET 3 AA2 3 PRO A 232 VAL A 233 1 O VAL A 233 N GLY A 203 SHEET 1 AA3 3 GLY A 327 PRO A 328 0 SHEET 2 AA3 3 GLY A 345 HIS A 347 -1 O HIS A 347 N GLY A 327 SHEET 3 AA3 3 VAL A 353 HIS A 355 -1 O VAL A 354 N TYR A 346 SHEET 1 AA4 2 LYS A 332 VAL A 335 0 SHEET 2 AA4 2 VAL A 338 VAL A 341 -1 O PHE A 340 N ILE A 333 SHEET 1 AA5 7 LEU A 673 TYR A 674 0 SHEET 2 AA5 7 SER A 397 ALA A 400 -1 N VAL A 398 O LEU A 673 SHEET 3 AA5 7 ASN A 386 LEU A 389 -1 N ASN A 386 O ALA A 400 SHEET 4 AA5 7 LYS C 127 ILE C 132 1 O MET C 129 N LEU A 389 SHEET 5 AA5 7 LEU C 184 ARG C 190 -1 O LEU C 184 N ILE C 132 SHEET 6 AA5 7 LEU C 153 VAL C 160 -1 N VAL C 160 O ILE C 185 SHEET 7 AA5 7 THR C 146 THR C 148 -1 N PHE C 147 O TRP C 154 SHEET 1 AA6 2 ASN A 414 PHE A 415 0 SHEET 2 AA6 2 PHE A 843 VAL A 844 -1 O VAL A 844 N ASN A 414 SHEET 1 AA7 3 PRO A 612 LEU A 614 0 SHEET 2 AA7 3 ASP A 761 ASN A 767 -1 O PHE A 766 N HIS A 613 SHEET 3 AA7 3 PHE A 753 LEU A 758 -1 N LEU A 758 O ASP A 761 SHEET 1 AA8 2 HIS A 816 THR A 817 0 SHEET 2 AA8 2 PRO A 830 TYR A 831 -1 O TYR A 831 N HIS A 816 SHEET 1 AA9 2 VAL A 820 GLN A 822 0 SHEET 2 AA9 2 ASP A 825 VAL A 827 -1 O VAL A 827 N VAL A 820 LINK O3' U P 13 P1 F86 P 14 1555 1555 1.56 LINK O3 F86 P 14 P1 F86 P 15 1555 1555 1.56 LINK O3 F86 P 15 P1 F86 P 16 1555 1555 1.56 LINK O3 F86 P 16 P1 F86 P 17 1555 1555 1.56 CISPEP 1 PHE A 504 PRO A 505 0 -2.21 CISPEP 2 TRP C 182 PRO C 183 0 -16.52 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000